Structures of aminoacylase 3 in complex with acetylated substrates

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 42, 2010, Pages 17962-17967

  Hsieh, Jennifer M ^a,b   Tsirulnikov, Kirill ^b   Sawaya, Michael R ^a   Magilnick, Nathaniel ^b   Abuladze, Natalia ^b   Kurtz, Ira ^b   Abramson, Jeff ^b   Pushkin, Alexander ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Mercapturates; Metalloprotein; X ray structure

Indexed keywords

ACETIC ACID; AMINO ACID; AMINOACYLASE; AMINOACYLASE 3; CYSTEINE; N ACETYL S 1,2 DICHLOROVINYL CYSTEINE; N ALPHA ACETYL TYROSINE; TYROSINE; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; CHEMICAL INTERACTION; CRYSTAL STRUCTURE; PRIORITY JOURNAL;

ACETYLATION; AMIDOHYDROLASES; ANIMALS; BIOCATALYSIS; MICE; MODELS, MOLECULAR; PROTEIN CONFORMATION; SUBSTRATE SPECIFICITY;

EID: 78149255968     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1006687107     Document Type: Article

References (38)

1. Anders M, Dekant W (1994) Aminoacylases. Adv Pharmacol 27:431-448.
2. Pushkin A, et al. (2004) Structural characterization, tissue distribution, and functional expression of murine aminoacylase III. Am J Physiol-Cell Ph 286(4):C848-C856.
3. Uttamsingh V, Keller DA, Anders MW (1998) Acylase I-catalyzed deacetylation of N-acetyl-L-cysteine and S-alkyl-N-acetyl-L-cysteines. Chem Res Toxicol 11(7):800-809.
4. Uttamsingh V, Anders MW (1999) Acylase-catalyzed deacetylation of haloalkene-derived mercapturates. Chem Res Toxicolol 12(10):937-942.
5. Le Coq J, An HJ, Lebrilla C, Viola RE (2006) Characterization of human aspartoacylase: The brain enzyme responsible for Canavan disease. Biochemistry 45(18):5878-5884.
6. Newman D, et al. (2007) Specificity of aminoacylase III mediated deacetylation of mercapturic acids. Drug Metab Dispos 35(1):43-50.
7. Lindner HA, et al. (2003) Essential roles of zinc ligation and enzyme dimerization for catalysis in the aminoacylase-1/M20 family. J Biol Chem 278(45):44496-44504.
8. Bitto E, Bingman CA, Wesenberg GE, McCoy JG, Phillips GN (2007) Structure of aspartoacylase, the brain enzyme impaired in Canavan disease. Proc Natl Acad Sci USA 104(2):456-461.
9. Le Coq J, et al. (2008) Examination of the mechanism of human brain aspartoacylase through the binding of an intermediate analogue. Biochemistry 47(11):3484-3492. (Pubitemid 351399236)
10. Tsirulnikov K, et al. (2009) Mouse aminoacylase 3: A metalloenzyme activated by cobalt and nickel. Biochim Biophys Acta 1794(7):1049-1057.
11. DeRosa CT, Johnson BL, Fay M, Hansen H, Mumtaz MM (1996) Public health implications of hazardous waste sites: Findings, assessment and research. Food Chem Toxicol 34(11-12):1131-1138. (Pubitemid 27124190)
12. Birner G, Bernauer U, Werner M, Dekant W (1997) Biotransformation, excretion and nephrotoxicity of haloalkene-derived cysteine S-conjugates. Arch Toxicol 72:1-8. (Pubitemid 28062386)
13. Dekant W, Vamvakas S, Anders M (1994) Formation and fate of nephrotoxic and cytotoxic glutathione S-conjugates: Cysteine conjugate â-lyase pathway. Adv Pharmacol 27:114-162.
14. Silber PM, Gandolfi AJ, Brendel K (1986) Early biological indicators of S-(1,2-dichlorovinyl)- L-cysteine nephrotoxicity in the rabbit. Drug Chem Toxicol 9(3-4):285-303.
15. Wolfgang GHI, Gandolfi AJ, Stevens JL, Brendel K (1989) N-acetyl S-(1,2-dichlorovinyl)- L-cysteine produces a similar toxicity to S-(1,2-dichlorovinyl)-L-cysteine in rabbit renal slices - differential transport and metabolism. Toxicol Appl Pharmacol 101(2):205-219.
16. 35S-1,2-dichlorovinyl-L-cysteine nephrotoxicity in vivo and in cultured proximal tubule epithelial-cells. Lab Invest 66(4):474-484.
17. Kays SE, Berdanier CD, Swagler AR, Lock EA, Schnellmann RG (1993) An in-vitro model of renal proximal tubule cell regeneration. J Pharmacol Toxicol Methods 29(4):211-215.
18. Cooper A (1994) Enzymology of cysteine S-conjugate beta-lyases. Adv Pharmacol 27:71-113.
19. Lash LH, Putt DA, Parker JC (2006) Metabolism and tissue distribution of orally administered trichloroethylene in male and female rats: Identification of glutathione-and cytochrome P-450-derived metabolites in liver, kidney, blood, and urine. J Toxicol Env Health A 69(13):1285-1309.
20. Anders MW, Dekant W (1998) Glutathione-dependent bioactivation of haloalkenes. Annu Rev Pharmacol Toxicol 38:501-537.
21. Bull RJ (2000) Mode of action of liver tumor induction by trichloroethylene and its metabolites, trichloroacetate and dichroloacetate. Environ Health Persp 108(Suppl 2): 241-259.
22. Barton HA, Clewell HJ, III (2000) Evaluating noncancer effects of trichloroethylene: dosimetry, mode of action, and risk assesment. Environ Health Persp 108(Suppl 2): 323-334.
23. Mangani S, Carloni P, Orioli P (1992) Crystal-structure of the complex between carboxypeptidase A and the biproduct analog inhibitor L-benzylsuccinate at 2.0 Å resolution. J Mol Biol 223(2):573-578.
24. Emsley P, Cowtan K (2004) Coot: Model-building tools for molecular graphics. Acta Crystallogr D 60:2126-2132.
25. Adams PD, et al. (2010) PHENIX: A comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D 66:213-221.
26. Ryazantsev S, et al. (2007) Structural characterization of dimeric murine aminoacylase III. FEBS Lett 581(9):1898-1902. (Pubitemid 46604817)
27. Holm L, Kaariainen S, Rosenstrom P, Schenkel A (2008) Searching protein structure databases with DaliLite v.3. Bioinformatics 24(23):2780-2781.
28. Christianson DW, Lipscomb WN (1989) Carboxypeptidase A. Accounts Chem Res 22(2):62-69.
29. Byers LD, Wolfende R (1973) Binding of by-product analog benzylsuccinic acid by carboxypeptidase A. Biochemistry 12(11):2070-2078.
30. Dekant W, Martens G, Vamvakas S, Metzler M, Henschler D (1987) Bioactivation of tetrachloroethylene. Role of glutathione S-transferase- catalyzed conjugation versus cytochrome P-450-dependent phospholipid alkylation. Drug Metab Dispos 15(5):702-709.
31. Lebrun P, Malaisse WJ, Herchuels A (1983) Impairment by aminoaxiacetate of ionic response to nutrients in pancreatic islets. Am J Physiol-Endoc M 245:E38-E46.
32. Guth PS, et al. (1990) Evaluation of amino-oxyacetic acid as a palliative in tinnitus. Ann Oto Rhinol Laryn 99:74-79.
33. Kurozumi Y, Abe T, Yao W-B, Ubuka T (1999) Experimentyal â-alaninuria induced by (aminooxy)acetate. Acta Med Okayama 53:13-18.
34. Subramanian RK, et al. (2007) Reassessment of the mechanism by which aminoaxyacetate (AOA) inhibits gluconeogenesis (GNG) from lactate. FASEB J 21:804.1.
35. Udenfriend S, et al. (1972) Fluorescamine - reagent for assay of amino-acids, peptides, proteins, and primary amines in picomole range. Science 178(4063):871-872.
36. Otwinowski Z, Minor W (1997) Processing of X-ray diffraction data collected in oscillation mode. Method Enzymol, eds CW Carter, Jr and RM Sweet (Academic, San Diego), 276, pp 307-326.
37. McCoy AJ, et al. (2007) Phaser crystallographic software. J Appl Crystallogr 40:658-674.
38. Collaborative Computational Project N (1994) The CCP4 suite: Programs for protein crystallography. Acta Crystallogr D 50(5):760-763.